AI-generated summary
The authors report treating two female patients with early-stage erythematotelangiectatic rosacea using a Q-switched 595-nm Nd:YAG laser at low fluence. They describe the treatment as safe and effective in these patients and suggest it may be an additional option. Because the report covers only two patients without a control group, the findings cannot be generalized.
- Participants
- 2
- Who or what was studied
- Two female Korean patients with early-stage erythematotelangiectatic rosacea
- Wavelengths
- 595 nm
- Limits stated in the abstract
- The report includes only two patients and no control group, so the results cannot be generalized.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.